WALTHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that eight abstracts were accepted for oral presentations at the 49th Macula Society ...
Opthea Limited to Present Sozinibercept Phase 2b Study Results at Macula Society 48th Annual Meeting
Opthea Limited announces presentation of sozinibercept data at the Macula Society Annual Meeting, showcasing superior outcomes in wet AMD treatment. Opthea Limited has announced that its novel therapy ...
Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1:00 PM PT (4:00 PM ET) Company to host an investor webcast on Monday, March 2 ...
BRISBANE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (ANNX) (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with ...
- Proprietary suprachoroidal injection platform demonstrates broad applicability across multiple retinal disorders- - CLS-AX will also be featured at the upcoming virtual Angiogenesis, Exudation, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results